Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Pharmacogenomics
|
August 7, 2008
Clozapine-induced agranulocytosis and its genetic determinants
Carolin Opgen-Rhein, Michael Dettling
JAMA
|
October 16, 2008
Escitalopram, problem-solving therapy, and poststroke depression
Michael Dettling, Carolin Opgen-Rhein, Ion Anghelescu
The New England Journal of Medicine
|
October 3, 2006
Homocysteine lowering and cognitive performance
Michael Dettling, Carolin Opgen-Rhein, Ion-George Anghelescu
Journal of Clinical Psychopharmacology
|
January 17, 2007
Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride
Carolin Opgen-Rhein, Andres H Neuhaus, Michael Dettling
Psychiatrische Praxis
|
December 9, 2004
[New strategies in schizophrenia: impact of endophentotypes]
Carolin Opgen-Rhein, Andres Neuhaus, Carsten Urbanek, et al.
JAMA
|
November 23, 2006
Fluoxetine for treatment of anorexia nervosa
Michael Dettling, Carolin Opgen-Rhein, Arnim Quante, et al.
Schizophrenia Bulletin
|
January 18, 2008
Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test
Carolin Opgen-Rhein, Andres H Neuhaus, Carsten Urbanek, et al.
Journal of Psychiatric Research
|
August 16, 2006
Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study
Andres H Neuhaus, Simone Koehler, Carolin Opgen-Rhein, et al.
Schizophrenia Research
|
March 9, 2011
Visual P3 amplitude modulation deficit in schizophrenia is independent of duration of illness
Andres H Neuhaus, Eric Hahn, Constanze Hahn, et al.
Psychiatry Research
|
May 26, 2009
Attention network test (ANT) reveals gender-specific alterations of executive function in schizophrenia
Carsten Urbanek, Andres Hao Ming Neuhaus, Carolin Opgen-Rhein, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Pharmacogenomics
|
August 7, 2008
Clozapine-induced agranulocytosis and its genetic determinants
Carolin Opgen-Rhein, Michael Dettling
JAMA
|
October 16, 2008
Escitalopram, problem-solving therapy, and poststroke depression
Michael Dettling, Carolin Opgen-Rhein, Ion Anghelescu
The New England Journal of Medicine
|
October 3, 2006
Homocysteine lowering and cognitive performance
Michael Dettling, Carolin Opgen-Rhein, Ion-George Anghelescu
Journal of Clinical Psychopharmacology
|
January 17, 2007
Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride
Carolin Opgen-Rhein, Andres H Neuhaus, Michael Dettling
Psychiatrische Praxis
|
December 9, 2004
[New strategies in schizophrenia: impact of endophentotypes]
Carolin Opgen-Rhein, Andres Neuhaus, Carsten Urbanek, et al.
JAMA
|
November 23, 2006
Fluoxetine for treatment of anorexia nervosa
Michael Dettling, Carolin Opgen-Rhein, Arnim Quante, et al.
Schizophrenia Bulletin
|
January 18, 2008
Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test
Carolin Opgen-Rhein, Andres H Neuhaus, Carsten Urbanek, et al.
Journal of Psychiatric Research
|
August 16, 2006
Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study
Andres H Neuhaus, Simone Koehler, Carolin Opgen-Rhein, et al.
Schizophrenia Research
|
March 9, 2011
Visual P3 amplitude modulation deficit in schizophrenia is independent of duration of illness
Andres H Neuhaus, Eric Hahn, Constanze Hahn, et al.
Psychiatry Research
|
May 26, 2009
Attention network test (ANT) reveals gender-specific alterations of executive function in schizophrenia
Carsten Urbanek, Andres Hao Ming Neuhaus, Carolin Opgen-Rhein, et al.
Page
of 2